Detection of Autoantibodies Against Nucleoporin p62 in Sera of Patients With Primary Biliary Cholangitis

키워드

참고문헌 (35)

1. Carey EJ, "Primary biliary cirrhosis", Lancet, 386, pp.1565~1575 (2015)
2. Invernizzi P, "Primary Biliary Cholangitis : advances in management and treatment of the disease", Dig Liver Dis, 49, pp.841~846 (2017)
3. Kim KA, "Population-based epidemiology of primary biliary cirrhosis in South Korea", Aliment Pharmacol Ther, 43, pp.154~162 (2016)
4. Boonstra K, "Epidemiology of primary sclerosing cholangitis and primary biliary cirrhosis : a systematic review", J Hepatol, 56, pp.1181~1188 (2012)
5. Benedetta Terziroli Beretta-Piccoli, "Geoepidemiology of Primary Biliary Cholangitis: Lessons from Switzerland", Clinical Reviews in Allergy & Immunology, 54(2), pp.295~306 (2018), Springer Science and Business Media LLC[DOI]
6. Ali AH, "Diagnosis and management of primary biliary cirrhosis", Expert Rev Clin Immunol, 10, pp.1667~1678 (2014)
7. Corrigan M, "Aspects of the pathophysiology of primary biliary cirrhosis", Dig Dis, 33, pp.102~108 (2015)
8. Cancado ELR, "The importance of autoantibody detection in primary biliary cirrhosis", Front Immunol, 6, pp.309~ (2015)
9. Kim KA, "The diagnosis and treatment of primary biliary cirrhosis", Korean J Hepatol, 17, pp.173~179 (2011)
10. Granito A, "Antinuclear antibodies as ancillary markers in primary biliary cirrhosis", Expert Rev Mol Diagn, 12, pp.65~74 (2012)
11. Bogdanos DP, "Disease-specific autoantibodies in primary biliary cirrhosis", Clin Chim Acta, 412, pp.502~512 (2011)
12. Yamagiwa S, "Autoantibodies in primary biliary cirrhosis : recent progress in research on the pathogenetic and clinical significance", World J Gastroenterol, 20, pp.2606~2612 (2014)
13. Bauer A, "Detection of anti-SP100 antibodies in primary biliary cirrhosis. Comparison of ELISA and immunofluorescence", J Immunoassay Immunochem, 34, pp.346~355 (2013)
14. Villalta D, "Autoantibody profiling of patients with primary biliary cirrhosis using a multiplexed line-blot assay", Clin Chim Acta, 438, pp.135~138 (2015)
15. de Liso F, "The diagnostic accuracy of biomarkers for diagnosis of primary biliary cholangitis(PBC)in anti-mitochondrial antibody(AMA)-negative PBC patients : a review of literature", Clin Chem Lab Med, 56, pp.25~31 (2017)
16. Gao L, "The value of antinuclear antibodies in primary biliary cirrhosis", Clin Exp Med, 8, pp.9~15 (2008)
17. Liu H, "PBC screen : an IgG", IgA dual isotype ELISA detecting multiple mitochondrial and nuclear autoantibodies specific for primary biliary cirrhosis, 2010, pp.35, 436~442
18. Invernizzi P, "Antinuclear antibodies in primary biliary cirrhosis", Semin Liver, 25, pp.298~310 (2005)
19. Tsangaridou E, "Differential detection of nuclear envelope autoantibodies in primary biliary cirrhosis using routine and alternative methods", BMC Gastroenterol, 10, pp.28~ (2010)
20. Bauer A, "Measurement of gp210 autoantibodies in sera of patients with primary biliary cirrhosis", J Clin Lab Anal, 21, pp.227~231 (2007)
21. Sasaki M, "A possible involvement of p62", sequestosome-1 in the process of biliary epithelial autophagy and senescence in primary biliary cirrhosis, 2012, pp.32, 487~499
22. Chantran Y, "Autoantibodies in primary biliary cirrhosis : antinuclear envelope autoantibodies", Clin Res Hepatol Gastroenterol, 38, pp.256~258 (2014)
23. Hu CJ, "Primary biliary cirrhosis : what do autoantibodies tell us", World J Gastroenterol, 16, pp.3616~3629 (2010)
24. European Association for the Study of the Liver, "EASL Clinical Practice Guidelines : management of cholestatic liver diseases", J Hepatol, 51, pp.237~267 (2009)
25. Alvarez F, "International Autoimmune Hepatitis Group Report : review of criteria for diagnosis of autoimmune hepatitis", J Hepatol, 31, pp.929~938 (1999)
26. Muratori P, "Characterization and clinical impact of antinuclear antibodies in primary biliary cirrhosis", Am J Gastroenterol, 98, pp.431~437 (2003)
27. Wesierska-Gadek J, "Autoantibodies against nucleoporin p62 constitute a novel marker of primary biliary cirrhosis", Gastroenterology, 110, pp.840~847 (1996)
28. Miyachi K, "Primary biliary cirrhosis sera recognize not only gp210 but also proteins of the p62 complex bearing N-acetylglucosamine residues from rat liver nuclear envelope. Anti-p62 complex antibody in PBC", Mol Biol Rep, 23, pp.227~234 (1996)
29. Wesierska-Gadek J, "Characterization of autoantibodies against components of the nuclear pore complexes : high frequency of anti-p62 nucleoporin antibodies", Ann N Y Acad Sci, 1109, pp.519~530 (2007)
30. Wesierska-Gadek J, "Characterization of the antibodies to p62 nucleoporin in primary biliary cirrhosis using human recombinant antigen", J Cell Biochem, 104, pp.27~37 (2008)
31. Invernizzi P, "Autoantibodies against nuclear pore complexes are associated with more active and severe liver disease in primary biliary cirrhosis", J Hepatol, 34, pp.366~372 (2001)
32. Lammers WJ, "Levels of alkaline phosphatase and bilirubin are surrogate end points of outcomes of patients with primary biliary cirrhosis : an international follow-up study", Gastroenterology, 147, pp.1338.e5~1349.e5 (2014)[DOI]
33. Murillo Perez CF, "Bilirubin is predictive of transplant-free survival even within the normal range in primary biliary cholangitis patients", Hepatology, 66, pp.41A~42A (2017)[DOI]
34. Wesierska-Gadek J, "Correlation of initial autoantibody profile and clinical outcome in primary biliary cirrhosis", Hepatology, 43, pp.1135~1144 (2006)
35. Gatselis NK, "Clinical significance of the fluctuation of primary biliary cirrhosis-related autoantibodies during the course of the disease", Autoimmunity, 46, pp.471~479 (2013)

관련 논문AI추천